Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2016

01-11-2016 | Stanford Multidisciplinary Seminars

Recurrent Pyogenic Cholangitis: Got Stones?

Authors: Sepideh Gholami, Lauren Wood, Gerald Berry, George Triadafilopoulos, Brendan C. Visser, Monica M. Dua

Published in: Digestive Diseases and Sciences | Issue 11/2016

Login to get access

Excerpt

A 48-year-old Vietnamese woman was initially evaluated for a history of recurrent abdominal pain lasting several months. She recalled that at age 16, while residing in Vietnam, she had been diagnosed with “worms in her bile ducts” and she was treated medically. After immigrating to the USA in her twenties, she had experienced bouts of severe abdominal pain associated with fever and chills every 2–3 years; since these episodes were largely self-limited, she had not sought medical attention. The same pain had recently recurred, becoming more persistent. At presentation, laboratory evaluation revealed relatively normal liver function tests, including a total bilirubin of 0.8 mg/dL, aspartate aminotransferase (AST) 50 U/L, alanine aminotransferase (ALT) 73 U/L, and a mildly elevated alkaline phosphatase level of 179 U/L. Abdominal ultrasonography revealed a 5-cm complex echogenic mass near the porta hepatis; a computed tomography (CT) scan demonstrated multiple stones and intrahepatic biliary dilatation limited to the left hepatic lobe. …
Literature
2.
go back to reference Teoh TB. A study of gallstones and included worms in recurrent pyogenic cholangitis. J Pathol Bacteriol. 1963;86:123–129.CrossRefPubMed Teoh TB. A study of gallstones and included worms in recurrent pyogenic cholangitis. J Pathol Bacteriol. 1963;86:123–129.CrossRefPubMed
3.
go back to reference Matsushiro T, Suzuki N, Sato T, Maki T. Effects of diet on glucaric acid concentration in bile and the formation of calcium bilirubinate gallstones. Gastroenterology. 1977;72:630–633.PubMed Matsushiro T, Suzuki N, Sato T, Maki T. Effects of diet on glucaric acid concentration in bile and the formation of calcium bilirubinate gallstones. Gastroenterology. 1977;72:630–633.PubMed
4.
5.
go back to reference Shoda J, Inada Y, Osuga T. Molecular pathogenesis of hepatolithiasis—a type of low phospholipid-associated cholelithiasis. Front Biosci. 2006;11:669–675.CrossRefPubMed Shoda J, Inada Y, Osuga T. Molecular pathogenesis of hepatolithiasis—a type of low phospholipid-associated cholelithiasis. Front Biosci. 2006;11:669–675.CrossRefPubMed
6.
go back to reference Kiriyama S, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo guidelines. J Hepato-Biliary-Pancreat Sci. 2012;19:548–556.CrossRef Kiriyama S, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo guidelines. J Hepato-Biliary-Pancreat Sci. 2012;19:548–556.CrossRef
7.
go back to reference Buxbaum JL, Lane CJ, Bagatelos KC, Ostroff JW. Long-term endoscopic management for primary recurrent pyogenic cholangitis. J Dig Endosc. 2014;5:64–68.CrossRef Buxbaum JL, Lane CJ, Bagatelos KC, Ostroff JW. Long-term endoscopic management for primary recurrent pyogenic cholangitis. J Dig Endosc. 2014;5:64–68.CrossRef
8.
go back to reference Koh YX, Chiow AKH, Chok AY, Lee LS, Tan SS, Ibrahim S. Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence. ISRN Surg. 2013;2013:536081. doi:10.1155/2013/536081. Koh YX, Chiow AKH, Chok AY, Lee LS, Tan SS, Ibrahim S. Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence. ISRN Surg. 2013;2013:536081. doi:10.​1155/​2013/​536081.
10.
go back to reference Tabrizian P, Jibara G, Shrager B, Schwartz ME, Roayaie S. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–626.CrossRefPubMed Tabrizian P, Jibara G, Shrager B, Schwartz ME, Roayaie S. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–626.CrossRefPubMed
11.
go back to reference Chen DW, Poon RTP, Liu CL, Fan ST, Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–393.CrossRefPubMed Chen DW, Poon RTP, Liu CL, Fan ST, Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–393.CrossRefPubMed
12.
go back to reference Otani K, Shimizu S, Chijiiwa K, et al. Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg. 1999;189:177–182.CrossRefPubMed Otani K, Shimizu S, Chijiiwa K, et al. Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg. 1999;189:177–182.CrossRefPubMed
13.
go back to reference Co M, Pang SY, Wong KY, Wai KI, Yuen WK. Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong. HPB. 2014;16:776–780.CrossRefPubMed Co M, Pang SY, Wong KY, Wai KI, Yuen WK. Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong. HPB. 2014;16:776–780.CrossRefPubMed
14.
go back to reference Kusano T, Isa T, Muto Y, Otsubo M. Long-term results of hepaticojejunostomy for hepatolithiasis. Am Surg. 2001;67:442.PubMed Kusano T, Isa T, Muto Y, Otsubo M. Long-term results of hepaticojejunostomy for hepatolithiasis. Am Surg. 2001;67:442.PubMed
15.
go back to reference Li SQ, Liang LJ, Peng BG, Lai JM, Lu MD, Li DM. Hepaticojejunostomy for hepatolithiasis: a critical appraisal. World J Gastroenterol WJG. 2006;12:4170–4174.CrossRefPubMed Li SQ, Liang LJ, Peng BG, Lai JM, Lu MD, Li DM. Hepaticojejunostomy for hepatolithiasis: a critical appraisal. World J Gastroenterol WJG. 2006;12:4170–4174.CrossRefPubMed
Metadata
Title
Recurrent Pyogenic Cholangitis: Got Stones?
Authors
Sepideh Gholami
Lauren Wood
Gerald Berry
George Triadafilopoulos
Brendan C. Visser
Monica M. Dua
Publication date
01-11-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3973-5

Other articles of this Issue 11/2016

Digestive Diseases and Sciences 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.